A 61-year-old man developed hypersensitivity pneumonitis and skin rash in close association with taking co-proxamol. These problems occurred in spite of being treated with prednisolone 40 mg daily (20 mg daily at the time of presentation) for assumed cranial arteritis. A therapeutic challenge with paracetamol was negative and the patient continues to take this drug. It seems likely that this patient's rash and hypersensitivity pneumonitis was caused by dextropropoxyphene. Dextropropoxyphene has not been reported previously as a cause of hypersensitivity pneumonitis.
Hypersensitivity pneumonitis is known to be caused by a large number of drugs, although it is more often associated with inhaled protein antigens. Co-proxamol, a combined preparation containing paracetamol and dextropropoxyphene, is a widely used analgesic and is well tolerated in recommended doses. Skin rash has been associated with its use 1 and two cases of paracetamol pneumonitis have been reported 2 3 but pulmonary complications of dextropropoxyphene have not been reported either in the literature or to the Committee on Safety of Medicines.
Case report
A 61-year-old man presented with a 2-month history of increasing breathlessness. He had stopped smoking 13 years previously because of cough, and for some years had been troubled with headache which had responded to corticosteroid therapy and a presumed diagnosis of cranial arteritis was made in 1988. Prednisolone therapy was withdrawn in 1992, but headaches recurred in early 1993. Prednisolone was restarted in a dose of 40 mg daily with only partial response and co-proxamol was taken as required to relieve headache. He then developed breathlessness which progressed steadily over a 2-month period. There was no exposure to any known causes of extrinsic allergic alveolitis and his only drug therapy was co-proxamol and prednisolone, the dose of which had been reduced to 20 mg daily. On examination there were bilateral lateinspiratory basal crackles audible. A chest X-ray had a vague shadowing in both lower zones suggesting an interstitial abnormality. An FEV 1 of 2.6 (predicted 3.4 ± 0.5 l) and an FVC of 4.1 (predicted 4.2 ± 0.7 l), together with the lung volumes and transfer coeYcient (see table) , suggested a combined obstructive and restrictive defect. Electrocardiogram and echocardiography were normal. Haematological indices, urea, electrolytes and standard liver function tests were normal, but there was an elevation of lactate dehydrogenase (LDH) of 531 IU/l (normal range 92-395). Serum was negative for Aspergillus fumigatus and avian precipitins and autoantibodies. Arterial blood gas analysis revealed mild hypoxaemia: PaO 2 8.9 kPa, PaCO 2 5.9 kPa, hydrogen ion 36.8 nmol/l. A ventilation/perfusion scan was normal. Exercise induced O 2 desaturation to 88% at 1.5 min at 40 watts.
It was concluded that this man had some form of interstitial lung disease which had developed while being treated with prednisolone (20-40 mg daily) for presumed cranial arteritis. A video-assisted thoracoscopic lung biopsy was performed.
PATHOLOGY
The biopsy taken from the left lower lobe measured 4.5 × 3 × 1.5 cm and had a normal macroscopic appearance. Histological examination showed the presence of a focal interstitial pneumonitis composed of lymphocytes, macrophages and occasional eosinophils (figure). Focally, this was also associated with evidence of an organising fibrinous exudate.
Granulomata were not identified. The inflammatory lesions had a predominantly centri-acinar distribution and were not associated with any significant degree of interstitial fibrosis. These histological appearances suggested a diagnosis of hypersensitivity pneumonitis. 4 
PROGRESS
Following the lung biopsy, co-proxamol was taken, mainly for chest pain, and breathlessness became more troublesome. A diVuse skin rash then developed. Co-proxamol was stopped and the rash disappeared within a few days and breathlessness improved. Co-proxamol was then reintroduced as a challenge and the rash recurred and breathlessness deteriorated again within a few hours of the first dose. Subsequently, a challenge with paracetamol caused no pulmonary or systemic reaction and this drug was continued as required for headache. The dose of prednisolone has been gradually reduced to 2 mg daily and the patient is now free from symptoms, except for occasional headache. Pulmonary function has also improved (table), the total lung capacity having increased by over one litre, and the serum LDH returned to normal.
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Discussion
This 61-year-old man developed hypersensitivity pneumonitis and skin rash in close association with taking co-proxamol. These problems occurred in spite of being treated with prednisolone in an initial dose of 40 mg (20 mg daily at the time of presentation) for assumed cranial arteritis. The diagnosis of cranial arteritis was not confirmed histologically, and seems unlikely, since the patient has remained well for almost 4 years while taking prednisolone in a small dose of 2 mg daily. A therapeutic challenge with paracetamol was negative and the patient continues to take this drug occasionally. A therapeutic challenge with dextropropoxyphene was considered too dangerous to perform, since the pulmonary problem developed when the patient was taking a large dose of prednisolone (30-40 mg daily) and the rash broke through treatment with this drug in a dose of 20 mg daily. It does, however, seem likely that both the rash and the hypersensitivity pneumonitis were caused by dextropropoxyphene. There was no evidence of an autoimmune disorder. The pulmonary symptoms developed many weeks after prednisolone was initially prescribed and then subsided after dextropropoxyphene was withdrawn and corticosteroid therapy reduced. This makes any other cause of the rash and the pneumonitis unlikely. Unfortunately, pulmonary function tests were not performed immediately before and after the challenge with co-proxamol, which caused recurrence of the skin rash and an increase in breathlessness. This challenge was performed in the patient's home and was supervised by his general practitioner.
We believe that this is the first reported case of dextropropoxyphene as a cause of hypersensitivity pneumonitis. We believe that pathologists and chest physicians encountering patients with an histological diagnosis of hypersensitivity pneumonitis should be aware of the possibility that this might represent a drug eVect. The idiopathic hypereosinophilic syndrome (HES) is an uncommon chronic disease of unknown aetiology characterised by a sustained overproduction of eosinophils that results in infiltration of multiple tissues. HES may result from eosinophilic diVerentiation of a clone of neoplastic cells or from reactive eosinophilia. In other patients, however, HES is idiopathic, 1 although this condition may include diVerent diseases. 2 Any organ system may be involved in idiopathic HES, the heart and the nervous system being the organs most commonly implicated. 3 Three types of neurologic manifestations have been described in this syndrome: encephalopathy, peripheral neuropathy, and focal central nervous system deficits from emboli or haemorrhage. 4 We report a patient with cerebellar manifestations and abnormal findings on magnetic resonance imaging (MRI), both of which reverted with therapy.
Case report
A 65-year-old woman was admitted to our hospital because of a 3-month history of recurrent dizziness, asthenia, and malaise. She had osteoarthritis of the knee and cervical spine without other relevant medical history. On admission, both neurological and general physical examination were normal. White blood cell count was 34.2 × 10 9 /l, 54% eosinophils, including eosinophilic myeloid precursors, 28% neutrophils, 11% lymphocytes, and 7% band forms, haemoglobin 137 g/l, platelet count 283 × 10 9 /l, and erythrocyte sedimentation rate 25 mm/h (normal less than 20). Routine chemical tests were normal except for alkaline phosphatase 555 U/l (98-279), gamma glutamyl transpeptidase 245 U/l (11-50), and alanine aminotransferase 82 U/l (1-40). Serum vitamin B12 level was 1096 pmol/l (174-713), and IgE level 260 IU/ml (less than 100). Antinuclear antibodies, rheumatoid factor, and antineutrophil cytoplasmic antibodies were negative. Alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and human chorionic gonadotropin were within normal limits. Several stool examinations for parasites were negative. Serologic tests for Brucella, Mycoplasma, Chlamydia, Toxoplasma, Q fever, syphilis, echinococcosis, fascioliasis, trichinosis, cytomegalovirus, and hepatitis B and C virus were negative. Chest radiographs and thoracic, abdominal and pelvic computed tomography (CT) were normal. A biopsy of bone marrow demonstrated marked eosinophilia (28%) with a shift to the left in eosinophil maturation. Liver biopsy revealed steatosis, portal tracts infiltrated by eosinophils that expanded into the parenchyma, and isolated hepatic cell necrosis.
On the 14th hospital day, the patient developed an unstable gait and ataxia of the left limbs. A cerebral CT was normal and a lumbar puncture yielded clear cerebrospinal fluid. Its analysis revealed 3 leukocytes/mm 3 , protein 0.30 g/l (normal less than 0.4), glucose 3.8 mmol/l (2.8-4.4), and normal cytological study and negative cultures. However, MRI showed hyperintense, vascular type lesions on T2-weighted images in both cerebellar hemi- A diagnosis of idiopathic HES was made, and treatment was started with prednisone, 1 mg/kg/day, and aspirin 200 mg/day. However, eosinophilia and neurologic manifestations persisted and 8 days later, hydroxyurea, 1500 mg daily, was added. This was followed by a clear improvement within the next few days. The patient was discharged on tapering doses of prednisone, which were withheld one month later, and hydroxyurea and aspirin. Two months later, the patient was asymptomatic with a maintenance dose of hydroxyurea of 1000 mg/day, and another MRI revealed that the hyperintense cerebellar lesions had practically resolved (figure 2). Serum levels of vitamin B12 and IgE were normal and white blood cell count was 6.3 × 10 9 /l, only 5% of which were eosinophils.
Discussion
Idiopathic HES is characterised by sustained eosinophilia and organ system damage. This overproduction of eosinophils might be caused by dysregulated production of eosinophilopoietic cytokines by T-lymphocyte clones. 2 5 The pathogenetic mechanisms of this disease are not known, although granular substances produced by eosinophils may play a role in the tissue injury. 2 3 5 In fact, the eosinophils of these patients have an increased propensity to release their granule proteins. 6 As mentioned above, involvement of the nervous system may take the form of focal deficits due to emboli or haemorrhage, generalised encephalopathy, and peripheral neuropathy. Peripheral neuropathy is the most common neurologic dysfunction. DiVerent types of neuropathy are seen in HES, including symmetric or asymmetric sensory polyneuropathy, mononeuritis multiplex, radiculopathy and muscle atrophy due to denervation. Nerve biopsy usually shows an axonal neuropathy. Nevertheless, in a few cases, vasculitis may be seen. 2 4 Encephalopathy is characterised by memory loss, altered behaviour, confusion, ataxia and upper motor neurone signs with increased muscle tone, hyperreflexia and a positive Babinski sign. Strokes or transient ischaemic episodes may be caused by thromboemboli originated in the heart. 4 However, thrombo-emboli may also occur without cardiac disease demonstrable by echocardiography. 2 In addition, local intravascular thrombosis might take place within the vessels of the nervous system, although this mechanism has not been confirmed. 2 Interestingly, an endothelial lesion, as a consequence of direct damage from infiltration of eosinophils, and the release of eosinophil-derived neurotoxin and eosinophil cationic protein, have been suggested as pathogenetic mechanisms of encephalopathy, peripheral neuropathy and cardiopathy. 3 4 The present case supports this mechanism because no evidence of intracardiac thrombi was found and both clinical manifestations and MRI findings quickly resolved after the onset of eVective antieosinophilic therapy.
The treatment of patients with idiopathic HES and organ involvement consists of prednisone. However, cytotoxic agents should be added if the patient does not respond to steroids. 3 Cytotoxic chemotherapy is used in order to lower the eosinophils count, given its potential capacity of tissular injury, although some manifestations of HES do not appear to correlate with the levels of eosinophils. 2 3 Hydroxyurea is the most common cytotoxic agent employed in HES. Its primary site of action is the ribonucleotide diphosphate reductase, which inhibits the formation of all marrow-derived cells. 2 Other treatment modalities have been used in patients in whom eosinophilia is refractory to conventional therapy. 7 8 Patients with neurological complications are more likely to be resistant to prednisone. 2 Our patient did not respond to steroid treatment and showed a remarkable clinical, analytical and radiologic improvement after hydroxyurea was started. To our knowledge, such a clear response, with MRI demonstration of the resolution of the lesions, has not been reported to date. This case suggests that anti-eosinophilic therapy should be initiated without delay once a diagnosis of HES is made in order to avoid permanent, structural damage. 
Summary points
+ idiopathic HES is an uncommon disease characterised by sustained eosinophilia and organ system damage + the nervous system is commonly involved, but neurological complications may be reversible with early therapy + treatment should be initiated as soon as HES is diagnosed order to avoid a permanent lesion Patients with aortic aneurysms are at increased risk of bacterial aortitis, Salmonellae being the commonest cause. 1 The diagnosis can be diYcult and a high index of suspicion is required on the part of the physician. We describe a case of Salmonella aortitis in a patient with a pre-existing aortic aneurysm. Despite a delayed diagnosis, the patient made a full recovery following aortic repair and antimicrobial therapy.
Case report
A 55-year-old man presented to a general surgical unit with a 3-day history of general malaise, fever and right iliac fossa pain. He had developed watery diarrhoea 3 weeks earlier and faecal culture had grown Salmonella typhimurium phage type 208 sensitive to ampicillin, ciprofloxacin, trimethroprim and gentamicin, but resistant to cefuroxime. He was managed conservatively by his general practitioner with resolution of symptoms prior to admission. His medical history included long-standing hypertension, an anterior myocardial infarction and quadruple coronary artery bypass grafting 6 and 8 years earlier, respectively, renal colic and a 5-cm diameter infrarenal abdominal aortic aneurysm. The latter had been diagnosed incidentally the year before during a hospital admission for pneumonia and an elective repair of this aneurysm had been cancelled when he was found to have poor left ventricular function. His medications were aspirin, diltiazem, enalapril, isosorbide mononitrate, frusemide and omeprazole. On examination his temperature was 38°C. Chest auscultation was normal and abdominal palpation revealed a tender but soft right iliac fossa and a nontender aortic aneurysm. Initial investigation showed a haemoglobin of 11.0 g/dl, a white cell count of 8.5 × 10 9 /l with a normal diVerential, a C-reactive protein of 168 mg/l and an amylase of 77 IU/l. A chest X-ray showed right basal atelectasis and an abdominal ultrasound scan revealed a 5-cm diameter infrarenal aortic aneurysm. Echocardiography showed no evidence of endocarditis. Microbiological analysis of blood, sputum, faeces and urine were negative. He was initially commenced on intravenous cefuroxime 750 mg and metronidazole 500 mg, both tid.
On day 2 he became hypotensive with a blood pressure of 70/40 mmHg. A central venous line was inserted for fluid management and he was commenced on intravenous ciprofloxacin 400 mg bid. Abdominal computed tomography (CT) scans on days 2 and 5 showed no evidence of either a change in size or leakage from the aneurysm but did identify small bilateral pleural eVusions and renal calculi. Despite continuing antimicrobial therapy he remained unwell with general malaise, and intermittent pyrexia and he developed severe left loin and iliac fossa pain. On day 13 he was transferred to the regional infectious disease unit where a bone scan showed isotope retention in the left ureter. Intravenous urography showed bilateral renal calculi and delayed emptying of the left ureter, and an abdominal CT scan confirmed an 8.5-cm diameter leaking aortic aneurysm with retroperitoneal extension causing compression of the left ureter (figure). Aortic aneurysm repair was performed using a straight celsoft/ rifampicin graft. At operation the aorta and surrounding tissues were inflamed, oedematous and friable. Microscopy of the aortic wall revealed the presence of Gram-negative bacilli, although bacterial culture was negative. He was discharged home 27 days after admission. Oral ciprofloxacin 500 mg bid was continued for one month after discharge and at out-patient reviews since there has been no evidence of persistent infection. The clinical findings were consistent with a diagnosis of Salmonella aortitis.
Discussion
Salmonella species are the commonest cause of bacterial aortitis accounting for one third of all cases. 1 This reflects the incidence of Salmonella infection in the community, 2 the fact that 3-8% of Salmonella infections result in bacteraemia, 3 4 and the predilection of Salmonellae to infect damaged tissues such as atherosclerotic vascular endothelium. 5 Patients are usually male, over 50 years old and may present in a variety of ways ranging from the typical features of a rupturing aortic aneurysm to pyrexia of unknown origin. There is often no history of gastroenteritis and back or abdominal pain in a patient with fever appears to be the most consistent feature. 6 7 A pulsatile abdominal mass is palpable in only 42% of cases. 7 In insidious presentations a high index of suspicion in the supervising physician is arguably the most important factor in making the diagnosis, which can be confirmed in most cases by CT scanning. 8 As in our patient, the latter may not be diagnostic and repeat scans or further imaging may be necessary. Blood culture is positive in three-quarters of all cases of Salmonella aortitis. 6 7 Optimum treatment requires early surgical intervention and an extended course of appropriate antimicrobial therapy, ciprofloxacin being the drug of choice for Salmonella infections. [6] [7] [8] [9] The diagnosis of Salmonella aortitis in our patient was based on a recent history of Salmonella enteritis in a patient with a pyrexial illness and a leaking aortic aneurysm. The diagnosis was confirmed by the finding of Gram-negative bacilli in the wall of the aorta and it is probable that blood and aortic wall cultures were negative because of the presence of antibiotics in these specimens. Treatment with omeprazole reduces gastric acidity and thereby increases the risk of Salmonella infection. 10 In addition, this patient was known to have atherosclerotic disease of the aorta and was therefore at increased risk of bacterial aortitis. 5 We believe that general practitioners and hospital physicians should have a low threshold for prescribing antimicrobial therapy for the treatment of gastroenteritis in patients likely to have atheromatous disease of the aorta.
Even with modern surgical and antimicrobial management, the mortality of Salmonella aortitis exceeds 40%. 6 7 This case demonstrates that in patients with an aortic aneurysm and pyrexial illness of unknown cause, bacterial aortitis should be quickly excluded.
Learning points
x patients with known or suspected atheromatous disease of the aorta are at increased risk of bacterial aortitis x Salmonellae are the commonest cause of bacterial aortitis and consideration should be given to antimicrobial therapy for gastroenteritis in at-risk patients x patients taking gastric acid suppressing drugs are at increased risk of Salmonella infection x bacterial aortitis is diYcult to diagnose and a high index of suspicion is therefore important x the most useful investigation is CT, but this may be negative With the current preference for orchidectomy in patients with suspicious testicular masses there is the risk of removing a potentially normal testis. Experience of a patient with a suspicious mass in a solitary testis which was subsequently found to have benign histology after testis-conserving surgery, prompted us to report the present case.
Case history
A 39-year-old man presented with a 6-week history of pain in the left groin and suprapubic area with increasing tenderness in the right testis. Fourteen years earlier he had undergone a left orchidectomy and chemotherapy (four cycles of bleomycin, etoposide and cisplatin) for stage 2C teratoma. Since that time he had been well apart from azospermia which had been detected prior to starting chemotherapy. Examination on this occasion revealed a tender solitary right testis with no palpable nodule. Doppler ultrasound revealed a 4-mm lesion with normal blood flow within the right testis. Serum -human chorionic gonadotropin ( -hCG) and -fetoprotein were not raised but on the basis of the ultrasound findings it was felt that the lesion probably represented a tumour and he was advised to undergo an orchidectomy.
He was concerned about having to take long-term testosterone replacement, and although he was aware that the most likely diagnosis was a second malignancy, was keen if possible to pursue testis conservation. He underwent exploration of the right testis through a groin incision. Intra-operative ultrasound using a 7.5 mH ultrasound probe was used to identify the lesion (figure 1), which was excised with a rim of surrounding normal tissue. A separate testicular biopsy was also performed. Despite the clinical prediction of a new primary malignancy, histology of the nodule revealed seminiferous tubules lined only by Sertoli cells and marked proliferation and hyperplasia of Leydig cells. The separate biopsy showed atrophic testis.
Discussion
This case highlights the problems of diagnosis of testicular masses. Ultrasound is the mainstay for imaging of the testis and has a sensitivity of 80-98%. 1 One of its limitations is that non-neoplastic lesions may mimic tumours. Magnetic resonance imaging (MRI) has no proven diagnostic benefit over ultrasound, but provides better localisation when partial orchidectomy is being considered (figure 2).
2 If this surgical approach is followed, then intraoperative ultrasound can be used, as in this case, to delimit the lesion and thus remove as little of the normal testis as possible.
Fine needle aspiration of a suspicious mass is not performed to confirm the diagnosis prior to surgery due to the theoretical risk of tracking at the needle site and scrotal recurrence, although how real this risk is with modern adujvant treatment is unknown. Semen cytology has proved useful but is positive in only 50% of cases. 3 Radical orchidectomy rather than partial orchidectomy via an inguinal approach is the operation of choice, as 90% of testicular germ cell tumours have associated carcinoma in situ (CIS) which progresses to invasive disease in 50% of cases within 5 years.
3 Partial orchid-
Figure 1
Intra-operative ultrasound revealing a 4-mm hypoechogenic nodule lying immediately on the surface of the exposed testis. The site was marked for excision ectomy has been used in benign testicular tumours and has also been described in patients developing a germ cell tumour in a solitary testis. 4 5 The issue of disease in a solitary testis is important as 5% of patients with germ cell tumours of the testis will develop a further tumour in the contralateral testis. 6 If radical orchidectomy is the treatment of choice then all patients developing bilateral disease will suVer infertility and be committed to life-long testosterone replacement, as well as suVer the psychological burden of bilateral orchidectomy. At present none of the existing treatment modalities for life-long androgen replacement ensure constant physiological testosterone levels, and patients can suVer from disturbances in their libido and sexual dysfunction. 7 Due to the risk of malignancy in the contralateral testis it is becoming routine in certain centres to biopsy the contralateral testis in patients who present with germ cell tumours looking for CIS. 6 7 Radiotherapy has been used successfully to eradicate CIS. Doses of 16-20Gy in 8-10 fractions have been given and result in infertility but allow the patient to retain some Leydig cell function, and often avoid testosterone replacement. 7 8 For those patients remaining fertile after unilateral orchidectomy who have contralateral CIS and wish to father a family, chemotherapy may be an option. Chemotherapy has not produced 100% durable suppression of CIS and such patients will require careful observation as the disease may recur in up to 50%. 7 In patients with a tumour in a solitary testis, the above techniques can be applied following partial orchidectomy, ie, partial orchidectomy is used to remove the tumour and then followed by radiotherapy to the testis or chemotherapy in order to eradicate or control CIS. 8 Another option in these patients is chemotherapy alone. Evidence for this has come from a series of 32 patients who presented with metastatic disease and received chemotherapy without undergoing orchidectomy. Fourteen of these patients had no residual disease in their testis after treatment, while 13 remained relapse-free for a median of 7 years, although there was one relapse at 12 years. 9 The advantages of using partial orchidectomy are well illustrated in this case as it allows a histological diagnosis to be made and a treatment plan formulated depending on the patient's wishes, particularly when considering issues of fertility and hormone replacement. It is especially important to consider these concerns in patient with a solitary testis but the same principles should be applied to all patients, as there are minor complications and psychological morbidity associated with orchidectomy.
A theoretical disadvantage is that partial orchidectomy and associated postoperative haematoma may distort the anatomy and make follow-up diYcult. Although data on this are limited, experience of follow-up in four patients by one of us (RTDO) has not been a problem provided findings from ultrasound and clinical examination are taken together. Three of these patients have also had MRI, which adds little, although it improves the ease of getting a three-dimensional perspective of the testis.
Our patient was found to have Leydig cell hyperplasia, a benign condition requiring no further treatment following excision. It has been reported in patients with testicular tumours secreting high levels of -hCG. There is a single case report of Leydig cell hyperplasia mimicking a testicular tumour in a patient treated 21 years previously for an extragonadal seminoma. 10 In this case the patient underwent orchidectomy for a benign condition.
In summary, ultrasound is not a foolproof method of diagnosing testicular tumours and if unnecessary orchidectomy for benign disease is to be avoided, an attempt at histological diagnosis must be made. At present this is best done by partial orchidectomy. If malignancy is confirmed then radical orchidectomy is not mandatory and radiotherapy or chemotherapy as discussed above should be considered. 
Learning points
x a histological diagnosis should be made prior to orchidectomy, especially in patients with a solitary testis x 90% of testicular germ cell tumours have associated CIS, which progresses to invasive disease in 50% of cases within 5 years x biopsy of the contralateral testis is often performed at the time of diagnosis to look for CIS as 5% of patients will develop bilateral testicular germ cell tumours x CIS can be treated with radiotherapy, which leads to infertilty but avoids testosterone replacement. If the patient wishes to preserve fertility, chemotherapy can be used with careful observation x partial orchidectomy followed by radiotherapy or chemotherapy to treat surrounding CIS, can be used as an alternative to orchidectomy Extramedullary myeloid cell tumour (EMT), also known as granulocytic sarcoma, is known to occur in 3-7% of patients with acute myeloid leukemia (AML). 1 2 It can occur at initial presentation or at relapse. We report a case of AML in relapse presenting with a large anterior chest wall mass which was confirmed to be EMT and which responded completely to a combination of chemotherapy and radiotherapy.
Case report
A 49-year-old man was diagnosed as a case of AML-M1 in May 1996. He failed to achieve remission after induction chemotherapy with idarubicin and cytosine arabinoside. Complete remission was achieved after re-induction chemotherapy with daunorubicin and cytarabine given for 3 and 7 days, respectively, in the standard dosages. He subsequently completed consolidation chemotherapy (total of three cycles). The first and third cycle of consolidation therapy were similar to the re-induction chemotherapy regimen. The second cycle consisted of intermediate dose cytosar (1 g/m 2 bid for 5 days). He subsequently received alphainterferon as part of research protocol to study the eYcacy of alpha-interferon during consolidation and maintenance. While on interferon therapy, he presented in November 1997, with a progressively increasing painless lump over the anterior chest wall in the midline, of 3 weeks duration. Examination revealed a performance status of I (ECOG), and a hard mass measuring 10 × 14 cm overlying the anterior chest wall (figure 1). It was fixed, non-tender and non-pulsatile with bluish discolouration of overlying skin. Hepatomegaly (3 cm) below the right costal margin and splenomegaly (4 cm) below the left costal margin were also noted. Investigations revealed haemoglobin 12 g/dl, total leucocyte count 26 × 10 9 /l and platelet count 338 × 10 9 /l. Peripheral smear revealed 40% blasts, 2% myelocytes, 20% neutrophils and 38% lymphocytes. Fine needle aspiration cytology (FNAC) of the chest wall mass revealed a cellular smear showing haemopoietic cells including 18% blasts, 6% myelocytes, 29% neutrophils, 12% monocytes, and 35% lymphocytes (figure 2), confirming the diagnosis of EMT. On cytochemistry, blasts were positive for myeloperoxidase. Immunocytochemistry (APAAP) revealed the blasts to be positive for CD34, CD13 and CD33 and negative for other T and B cell markers. X-Rays of sternum and the bone scan were normal. Thus, a diagnosis of AML with relapse and EMT of the anterior chest wall, was made.
The patient received chemotherapy including daunorubicin and cytarabine for 3 and 7 days, respectively. He also received local radiotherapy to the mass using 12 Mev electrons (dose = 8 Gy/single fraction). Following this therapy, he achieved complete remission and the chest wall mass disappeared, leaving behind only the skin discolouration. The patient has now completed consolidation chemotherapy using high-dose cytosar, and was doing well on maintenance therapy with cytarabine and 6-mercaptopurine at last follow-up in September 1998.
Discussion
The term EMT refers to a solid tumour of any organ recognisable microscopically as a sarcoma, composed of leukaemic cells of the myeloid series. The term EMT encompasses all terms of extrameningeal, non-medullary leukaemic infiltrates. 2 Skin is one of the commonest sites of involvement. An autopsy study revealed that observable tumour nodules were most frequent in the orbit and in the chest wall. 3 EMT may appear as an isolated disease, during the course of the illness, or may antedate it by a few days to months. In this patient soft tissue swelling diagnosed as EMT developed during the course of illness. This patient presented with EMT of skin of anterior chest wall and was also found to be in medullary relapse. Underlying bony involvement (of sternum/ribs) was excluded by a normal bone scan.
Acute monocytic and myelomonocytic leukaemias have a higher frequency of overt infiltrative tissue lesions than other forms of AML. Previous studies have shown that EMT is most commonly associated with AML-M4. 2 This patient had been diagnosed as AML-M1 and later progressed to develop EMT.
The present case report highlights certain important findings. Meticulous FNAC of the swelling should be an essential component of the initial diagnostic work-up of patients with haematological malignancy who develop soft tissue swelling. FNAC smears stained with Jenner-Giemsa (Romanowsky stain) give a diagnostic picture showing the presence of myeloid and erythroid precursors, azurophilic granules, and Auer rods, making the diagnosis quick and easy. Therefore, for the diagnosis of EMT, morphological examination of a JennerGiemsa stained FNAC smear is a must and may be accompanied by cytochemical (MPO, NSE) and immunocytochemical (CD13, CD14, CD33, CD43, anti-MPO) stains, as done in our case.
Patients who present with EMT at AML relapse have always been treated with systemic re-induction chemotherapy. The tumour response to local external radiotherapy in combination with chemotherapy has been well documented. [4] [5] [6] This patient also showed complete response to chemotherapy with daunorubicin and cytosine arabinoside and local electron beam therapy. He achieved haematological remission and there is no evidence of local tumour. Prognosis for patients with EMT is related to the course of the underlying disease process. Survival in such patients has been reported to range from one to 30 months after the onset of EMT. In the western hemisphere, predominantly non-nutritional forms of rickets and osteomalacia are now seen. In this report we discuss a family with X-linked hypophosphataemic rickets from the Kashmir region of the Indian subcontinent (which is an uncommon entity here).
Keywords: hypophosphataemia; rickets
Nutritional deficiency is no longer an important cause of rickets in the western world, although it still is in India. 1 Rickets and osteomalacia can occur in association with a variety of disorders of proximal renal tubular function; these disorders have in common increased renal clearance of inorganic phosphates and hypophosphataemia with a normal glomerular filtration rate. Primary hypophosphataemic rickets is characterised by severe short stature and rickets in association with hypophosphataemia and hyperphosphaturia and usually has an X-linked mode of inheritance. 2 In this report we describe a family with hypophosphataemic rickets where we believe the mode of transmission is X-linked dominant. A Medline search for the last 30 years revealed only one such family described from India so far. 3 
Case report
Index case A 3-year-old girl, 5th in birth order was born of a full term normal delivery at home. She had failed to thrive since the age of 2 years. There was no suggestion of any chronic systemic disease. Examination revealed a well-nourished girl, height 79 cm, weight 10 kg (expected 50th percentiles for her height and weight: 94 cm and 10.5 kg, respectively). Upper segment lower segment ratio was 1.23. She had frontal bossing, widening of epiphyseal ends of long bones with knock knees, rachitic rosary, Harrison's sulcus and pigeon chest deformity. Family history was significant (figures 1 and 2). Of her four siblings, the three males (E-G) were normal while the other girl (B) was aVected. Her father (C ) and paternal uncle (D) were aVected while her mother was normal. Her paternal grandmother, who had died 10 years earlier, was also reported to have had short stature and leg deformities.
Other aVected cases Elder sister (B):
Although she had a chronological age of 16 years, there had also been a failure of linear growth since the age of 3 years, and she had gradually developed deformities of the lower limbs. She had attained menarche at age 14 years and was having regular cycles. Examination revealed a height of 134 cm and weight of 35 kg (expected 50th percentiles were 157 cm and 47.5 kg, respectively). She had mild pallor, knock knees, mild anterior bowing of legs, widening of epiphyses and pigeon chest deformity. Systemic examination was normal.
Father (C):
Aged 48 years, he had developed progressive deformity of upper and lower limbs during his childhood. He was 140 cm tall (corresponding to a height age of 11 years) and weighed 42 kg (consistent with his present height). He had multiple bony deformities including bowing of legs, bending of forearms, lumbar kyphoscoliosis. Systemic examination was normal. Full blood count, serum and urinary calcium, and ammonium chloride test were normal in all subjects, and none of them had proteinuria or glycosuria. Radiological screening revealed advanced changes of rickets/osteomalacia in the aVected subjects (figures 3 and 4). There was a mild elevation of total alkaline phosphatase in the aVected subjects, all of whom had persistent hypophosphataemia. Mean serum phosphorous was 1.9 mg/dl in aVected members and 4.5 mg/dl in unaVected ones (normal range, 3.0-4.5 mg/dl). Our index case, surprisingly, had high serum 25-hydroxyvitamin D (> 100 ng/ml) and undetectable (<5 pg/ml) 1,25-dihydroxyvitamin D. This biochemical abnormality was reproducible. Serum levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D were normal in other aVected as well as unaVected subjects (table) .
Discussion
In India, malnutrition continues to be the leading cause of rickets, although other causes of rickets are increasingly recognised. 4 In this study we describe a family in which all the female children had advanced changes of rickets/osteomalacia while the male children were spared. Their father and paternal uncle were aVected while their mother was normal. Historically, their paternal grandmother had also been aVected. Thus, it is evident that transmission of the disease is X-linked dominant.
In developed nations nutritional rickets, primarily due to vitamin D deficiency, has almost been eliminated as a result of fortification of some foods. By the 1940s vitamin D deficiency was no longer considered to be an important cause of osteomalacia and rickets. In North America the most common form of inherited rickets is X-linked dominant hypophosphataemic rickets. 5 This entity was first described by Albright and co-workers in 1937. 6 The phenotypic trait of hypophosphataemia is transmitted on the X-chromosome. Patients with familial hypophosphataemic rickets are recognised by marked rickets with hypophosphataemia and hyperphosphaturia coupled with increased serum alkaline phosphatase with normal or slightly reduced serum calcium; urinary phosphate excretion is high, despite hypophosphataemia indicating a defect in renal tubular reabsorption of phosphate. Phosphaturia is unassociated with either aminoaciduria, glucosuria, bicarbonaturia, or kaliuria. 7 Serum levels of immunoreactive parathyroid hormone are either normal or mildly increased. 8 Serum levels of 25-hydroxyvitamin D are normal whereas 1,25-dihydroxyvitamin D levels are either normal or low. 9 10 Our index case had elevated 25-hydroxyvitamin D levels with undetectable 1,25-dihydroxyvitamin D. The only logical explanation for this biochemical abnormality could be a concomitant sporadic 1 -hydroxylase deficiency.
Children aVected with this disorder progressively develop lower limb deformities once they begin to walk and bear weight. The deformities progressively worsen in an otherwise wellnourished and healthy child. The rate of linear growth is at first normal and then slowed, ultimately resulting in short stature. 2 On the basis of restriction fragment polymorphism studies in several kindred of X-linked hypophosphataemia, the mutant gene has been mapped to the short arm of the X-chromosome (Xp22.1). A candidate gene called PEx that exhibits homology to a family of endopeptidase genes has been identified and several mutations, including deletions, frame shifts and splice-junction defects, have been reported. 10 Treatment of this disorder continues to be a therapeutic challenge. Administration of 1,25-dihydroxyvitamin D and phosphates significantly improves the clinical course of this disease in childhood. 11 A similar therapeutic regimen results in significant clinical and histomorphometric improvement in adults with this disorder. 12 
